nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—ALB—focal segmental glomerulosclerosis	0.323	1	CbGaD
Pitavastatin—SLC10A1—Cyclosporine—focal segmental glomerulosclerosis	0.32	0.486	CbGbCtD
Pitavastatin—SLCO1B1—Cyclosporine—focal segmental glomerulosclerosis	0.0921	0.14	CbGbCtD
Pitavastatin—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.0809	0.123	CbGbCtD
Pitavastatin—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.0732	0.111	CbGbCtD
Pitavastatin—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.039	0.0591	CbGbCtD
Pitavastatin—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0272	0.0412	CbGbCtD
Pitavastatin—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0264	0.04	CbGbCtD
Pitavastatin—Rosuvastatin—ALB—focal segmental glomerulosclerosis	0.000846	1	CrCbGaD
Pitavastatin—ALB—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.000715	0.0926	CbGpPWpGaD
Pitavastatin—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.000598	0.123	CcSEcCtD
Pitavastatin—SLC10A1—kidney—focal segmental glomerulosclerosis	0.000572	0.121	CbGeAlD
Pitavastatin—UGT2B7—kidney—focal segmental glomerulosclerosis	0.000536	0.113	CbGeAlD
Pitavastatin—HMGCR—nephron tubule—focal segmental glomerulosclerosis	0.000451	0.0953	CbGeAlD
Pitavastatin—HMGCR—Statin Pathway—LIPC—focal segmental glomerulosclerosis	0.000421	0.0545	CbGpPWpGaD
Pitavastatin—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000419	0.0863	CcSEcCtD
Pitavastatin—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.000415	0.0855	CcSEcCtD
Pitavastatin—HMGCR—kidney—focal segmental glomerulosclerosis	0.000396	0.0838	CbGeAlD
Pitavastatin—HMGCR—cortex of kidney—focal segmental glomerulosclerosis	0.000386	0.0816	CbGeAlD
Pitavastatin—SLCO1B1—kidney—focal segmental glomerulosclerosis	0.000379	0.0802	CbGeAlD
Pitavastatin—SLCO2B1—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.00036	0.0467	CbGpPWpGaD
Pitavastatin—SLCO2B1—kidney—focal segmental glomerulosclerosis	0.000335	0.071	CbGeAlD
Pitavastatin—SLC10A1—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000333	0.0431	CbGpPWpGaD
Pitavastatin—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.000332	0.0684	CcSEcCtD
Pitavastatin—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.000327	0.0692	CbGeAlD
Pitavastatin—ABCC2—kidney—focal segmental glomerulosclerosis	0.000288	0.0608	CbGeAlD
Pitavastatin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.000285	0.037	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.000281	0.0365	CbGpPWpGaD
Pitavastatin—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.00028	0.0592	CbGeAlD
Pitavastatin—HMGCR—Statin Pathway—LPL—focal segmental glomerulosclerosis	0.000257	0.0333	CbGpPWpGaD
Pitavastatin—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.000239	0.0505	CbGeAlD
Pitavastatin—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.000237	0.0489	CcSEcCtD
Pitavastatin—CYP2C8—kidney—focal segmental glomerulosclerosis	0.000216	0.0456	CbGeAlD
Pitavastatin—SLCO1B3—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000208	0.027	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000191	0.0248	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.000189	0.0245	CbGpPWpGaD
Pitavastatin—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000177	0.0364	CcSEcCtD
Pitavastatin—SLC10A1—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000174	0.0225	CbGpPWpGaD
Pitavastatin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00016	0.033	CcSEcCtD
Pitavastatin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.0304	CcSEcCtD
Pitavastatin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.000147	0.019	CbGpPWpGaD
Pitavastatin—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000147	0.0302	CcSEcCtD
Pitavastatin—SLCO1B1—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.00014	0.0181	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000134	0.0173	CbGpPWpGaD
Pitavastatin—HMGCR—SREBP signalling—LPL—focal segmental glomerulosclerosis	0.000128	0.0166	CbGpPWpGaD
Pitavastatin—HMGCR—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000128	0.0165	CbGpPWpGaD
Pitavastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000125	0.0162	CbGpPWpGaD
Pitavastatin—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000123	0.0254	CcSEcCtD
Pitavastatin—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000121	0.0157	CbGpPWpGaD
Pitavastatin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000119	0.0246	CcSEcCtD
Pitavastatin—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000118	0.0249	CbGeAlD
Pitavastatin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000116	0.0239	CcSEcCtD
Pitavastatin—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000111	0.0144	CbGpPWpGaD
Pitavastatin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000109	0.0225	CcSEcCtD
Pitavastatin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000109	0.0225	CcSEcCtD
Pitavastatin—SLCO1B3—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000109	0.0141	CbGpPWpGaD
Pitavastatin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000108	0.0223	CcSEcCtD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.000106	0.0138	CbGpPWpGaD
Pitavastatin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000106	0.0218	CcSEcCtD
Pitavastatin—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000104	0.0135	CbGpPWpGaD
Pitavastatin—ABCB1—kidney—focal segmental glomerulosclerosis	0.000103	0.0219	CbGeAlD
Pitavastatin—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000101	0.0213	CbGeAlD
Pitavastatin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	9.54e-05	0.0197	CcSEcCtD
Pitavastatin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	9.47e-05	0.0195	CcSEcCtD
Pitavastatin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	9.22e-05	0.019	CcSEcCtD
Pitavastatin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	9.03e-05	0.0186	CcSEcCtD
Pitavastatin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	8.95e-05	0.0185	CcSEcCtD
Pitavastatin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	8.63e-05	0.0178	CcSEcCtD
Pitavastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	8.6e-05	0.0111	CbGpPWpGaD
Pitavastatin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	8.56e-05	0.0177	CcSEcCtD
Pitavastatin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	8.32e-05	0.0172	CcSEcCtD
Pitavastatin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	8.28e-05	0.0171	CcSEcCtD
Pitavastatin—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	8.03e-05	0.0104	CbGpPWpGaD
Pitavastatin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	7.71e-05	0.0159	CcSEcCtD
Pitavastatin—HMGCR—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	7.56e-05	0.0098	CbGpPWpGaD
Pitavastatin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	7.51e-05	0.0155	CcSEcCtD
Pitavastatin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	7.41e-05	0.0153	CcSEcCtD
Pitavastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	7.4e-05	0.00959	CbGpPWpGaD
Pitavastatin—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	7.37e-05	0.00955	CbGpPWpGaD
Pitavastatin—SLCO1B1—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	7.32e-05	0.00949	CbGpPWpGaD
Pitavastatin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	7.16e-05	0.0148	CcSEcCtD
Pitavastatin—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	7.11e-05	0.00921	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	7.01e-05	0.00908	CbGpPWpGaD
Pitavastatin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	6.92e-05	0.0143	CcSEcCtD
Pitavastatin—Rash—Cyclosporine—focal segmental glomerulosclerosis	6.6e-05	0.0136	CcSEcCtD
Pitavastatin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	6.6e-05	0.0136	CcSEcCtD
Pitavastatin—Headache—Cyclosporine—focal segmental glomerulosclerosis	6.56e-05	0.0135	CcSEcCtD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	6.55e-05	0.00849	CbGpPWpGaD
Pitavastatin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	6.22e-05	0.0128	CcSEcCtD
Pitavastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	6.01e-05	0.00779	CbGpPWpGaD
Pitavastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	5.1e-05	0.00661	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	4.97e-05	0.00643	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	4.95e-05	0.00641	CbGpPWpGaD
Pitavastatin—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	4.9e-05	0.00635	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.77e-05	0.00618	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.2e-05	0.00544	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	4.18e-05	0.00542	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	4.09e-05	0.0053	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.89e-05	0.00504	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	3.62e-05	0.00469	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	3.54e-05	0.00459	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.53e-05	0.00458	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.43e-05	0.00444	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	3.17e-05	0.00411	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	3.03e-05	0.00393	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.99e-05	0.00387	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.91e-05	0.00377	CbGpPWpGaD
Pitavastatin—SLCO2B1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	2.87e-05	0.00372	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.76e-05	0.00357	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	2.7e-05	0.0035	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	2.69e-05	0.00348	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	2.66e-05	0.00345	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.63e-05	0.00341	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	2.58e-05	0.00334	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	2.55e-05	0.0033	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	2.53e-05	0.00328	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.49e-05	0.00323	CbGpPWpGaD
Pitavastatin—UGT1A3—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	2.39e-05	0.00309	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.37e-05	0.00308	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	2.37e-05	0.00307	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	2.26e-05	0.00293	CbGpPWpGaD
Pitavastatin—SLCO1B3—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	2.24e-05	0.0029	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	2.21e-05	0.00287	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.13e-05	0.00275	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	2.11e-05	0.00273	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	2.05e-05	0.00266	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.03e-05	0.00263	CbGpPWpGaD
Pitavastatin—UGT2B7—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	2.03e-05	0.00263	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.01e-05	0.0026	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	1.98e-05	0.00257	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.97e-05	0.00256	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.91e-05	0.00248	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.87e-05	0.00242	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.85e-05	0.0024	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.82e-05	0.00236	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.77e-05	0.00229	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—LIPC—focal segmental glomerulosclerosis	1.73e-05	0.00225	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.72e-05	0.00223	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.72e-05	0.00222	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	1.71e-05	0.00221	CbGpPWpGaD
Pitavastatin—ABCC2—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	1.61e-05	0.00208	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.56e-05	0.00202	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.56e-05	0.00202	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CTGF—focal segmental glomerulosclerosis	1.53e-05	0.00198	CbGpPWpGaD
Pitavastatin—SLCO1B1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	1.51e-05	0.00195	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.46e-05	0.00189	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—LIPC—focal segmental glomerulosclerosis	1.41e-05	0.00183	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.41e-05	0.00182	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	1.4e-05	0.00181	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	1.37e-05	0.00177	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—LIPC—focal segmental glomerulosclerosis	1.33e-05	0.00172	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	1.33e-05	0.00172	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—LPL—focal segmental glomerulosclerosis	1.3e-05	0.00168	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CTGF—focal segmental glomerulosclerosis	1.24e-05	0.00161	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1.24e-05	0.0016	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.23e-05	0.00159	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	1.22e-05	0.00158	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—LIPC—focal segmental glomerulosclerosis	1.2e-05	0.00156	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.2e-05	0.00155	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	1.18e-05	0.00153	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CTGF—focal segmental glomerulosclerosis	1.17e-05	0.00152	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.15e-05	0.0015	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.15e-05	0.00149	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.15e-05	0.00148	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.14e-05	0.00148	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AGT—focal segmental glomerulosclerosis	1.11e-05	0.00144	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.08e-05	0.0014	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.06e-05	0.00137	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—LPL—focal segmental glomerulosclerosis	1.06e-05	0.00137	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CTGF—focal segmental glomerulosclerosis	1.06e-05	0.00137	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.05e-05	0.00136	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	1.02e-05	0.00132	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.02e-05	0.00132	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.01e-05	0.00131	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	9.81e-06	0.00127	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.74e-06	0.00126	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	9.39e-06	0.00122	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	9.28e-06	0.0012	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AGT—focal segmental glomerulosclerosis	9.05e-06	0.00117	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—LIPC—focal segmental glomerulosclerosis	8.94e-06	0.00116	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—LPL—focal segmental glomerulosclerosis	8.62e-06	0.00112	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—ALB—focal segmental glomerulosclerosis	8.52e-06	0.0011	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—LIPC—focal segmental glomerulosclerosis	8.28e-06	0.00107	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	8.27e-06	0.00107	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	8.15e-06	0.00106	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—LPL—focal segmental glomerulosclerosis	8.12e-06	0.00105	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	8.05e-06	0.00104	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CTGF—focal segmental glomerulosclerosis	7.87e-06	0.00102	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.65e-06	0.000991	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AGT—focal segmental glomerulosclerosis	7.37e-06	0.000955	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—LPL—focal segmental glomerulosclerosis	7.33e-06	0.00095	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	7.29e-06	0.000945	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.25e-06	0.00094	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	7.08e-06	0.000918	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.04e-06	0.000912	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7e-06	0.000907	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AGT—focal segmental glomerulosclerosis	6.95e-06	0.0009	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ALB—focal segmental glomerulosclerosis	6.94e-06	0.000899	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.72e-06	0.00087	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AGT—focal segmental glomerulosclerosis	6.27e-06	0.000812	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	6.2e-06	0.000803	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	6.1e-06	0.00079	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	6.08e-06	0.000788	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.02e-06	0.000781	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	6.01e-06	0.000778	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.99e-06	0.000776	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.73e-06	0.000743	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ALB—focal segmental glomerulosclerosis	5.66e-06	0.000733	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—LPL—focal segmental glomerulosclerosis	5.46e-06	0.000707	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ALB—focal segmental glomerulosclerosis	5.33e-06	0.000691	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	5.14e-06	0.000666	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	5.11e-06	0.000662	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	5.06e-06	0.000655	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	5.05e-06	0.000655	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.9e-06	0.000635	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALB—focal segmental glomerulosclerosis	4.81e-06	0.000623	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AGT—focal segmental glomerulosclerosis	4.67e-06	0.000605	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.62e-06	0.000599	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	4.52e-06	0.000586	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	4.5e-06	0.000583	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	4.48e-06	0.00058	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	4.32e-06	0.00056	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	4.18e-06	0.000542	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.17e-06	0.00054	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.14e-06	0.000537	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.94e-06	0.000511	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.83e-06	0.000496	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.76e-06	0.000487	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	3.68e-06	0.000477	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.63e-06	0.000471	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALB—focal segmental glomerulosclerosis	3.58e-06	0.000464	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.39e-06	0.00044	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	3.32e-06	0.00043	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.19e-06	0.000414	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	3.14e-06	0.000406	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	3.12e-06	0.000404	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	2.73e-06	0.000354	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	2.68e-06	0.000348	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	2.67e-06	0.000346	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	2.55e-06	0.000331	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	2.34e-06	0.000303	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	2.18e-06	0.000283	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	2.06e-06	0.000267	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	1.79e-06	0.000232	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.68e-06	0.000217	CbGpPWpGaD
